Best TWAS P=1.112537e-15 · Best GWAS P=5.318548e-16 conditioned to 2.154471e-273
# | Tissue | Gene | Modality | RNA phenotype | h2 | eQTL R2 | model | # weights | model R2 | model R2 P | eQTL GWAS Z | TWAS Z | TWAS P | Top SNP corr | PP3 | PP4 | joint |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Adipose | Ctsc | alternative polyA | ENSRNOT00000022342 | 0.16 | 0.14 | blup | 2515 | 0.17 | 2.8e-18 | 4.4 | 5.9 | 3.8e-09 | -0.85 | 1.00 | 0.00 | FALSE |
2 | Adipose | Ctsc | alternative polyA | ENSRNOT00000097085 | 0.17 | 0.13 | blup | 2515 | 0.19 | 1.5e-20 | 4.3 | -6.1 | 9.9e-10 | 0.88 | 0.98 | 0.02 | FALSE |
3 | Adipose | Ctsc | isoform ratio | ENSRNOT00000022342 | 0.16 | 0.10 | blup | 2515 | 0.16 | 4.3e-17 | 4.4 | 6.1 | 8.5e-10 | -0.88 | 0.83 | 0.17 | FALSE |
4 | Adipose | Ctsc | isoform ratio | ENSRNOT00000097085 | 0.18 | 0.11 | blup | 2515 | 0.18 | 1.3e-19 | -6.9 | -6.3 | 3.1e-10 | 0.90 | 0.64 | 0.36 | FALSE |
5 | Adipose | Ctsc | intron excision ratio | chr1:142031177:142036233 | 0.05 | 0.03 | blup | 2515 | 0.04 | 6.5e-05 | -7.4 | -6.6 | 5.7e-11 | 0.92 | 0.39 | 0.60 | FALSE |
6 | Adipose | Ctsc | intron excision ratio | chr1:142031177:142045569 | 0.04 | 0.01 | blup | 2515 | 0.02 | 4.7e-03 | -7.4 | 6.2 | 5.3e-10 | -0.89 | 0.47 | 0.51 | FALSE |
7 | BLA | Ctsc | alternative polyA | ENSRNOT00000022342 | 0.07 | 0.00 | blup | 2518 | 0.01 | 5.1e-02 | -6.3 | 6.1 | 1.3e-09 | -0.74 | 0.46 | 0.19 | FALSE |
8 | BLA | Ctsc | alternative polyA | ENSRNOT00000097085 | 0.07 | 0.00 | blup | 2518 | 0.02 | 3.2e-02 | 2.8 | -5.8 | 5.8e-09 | 0.70 | 0.46 | 0.16 | FALSE |
9 | BLA | Ctsc | gene expression | ENSRNOG00000016496 | 0.12 | 0.10 | top1 | 1 | 0.10 | 5.0e-06 | -6.5 | -6.5 | 6.5e-11 | 0.95 | 0.35 | 0.03 | FALSE |
10 | BLA | Ctsc | mRNA stability | ENSRNOG00000016496 | 0.05 | 0.03 | top1 | 1 | 0.03 | 1.5e-02 | -8.0 | 8.0 | 1.1e-15 | -0.90 | 0.09 | 0.15 | FALSE |
11 | Brain | Grm5 | gene expression | ENSRNOG00000016429 | 0.16 | 0.10 | lasso | 6 | 0.15 | 5.3e-14 | -7.0 | 6.5 | 6.1e-11 | -0.86 | 0.29 | 0.71 | FALSE |
12 | Brain | Ctsc | gene expression | ENSRNOG00000016496 | 0.23 | 0.27 | blup | 2518 | 0.31 | 4.5e-29 | 4.3 | -5.9 | 3.8e-09 | 0.84 | 1.00 | 0.00 | FALSE |
13 | Brain | Ctsc | isoform ratio | ENSRNOT00000022342 | 0.03 | 0.04 | top1 | 1 | 0.04 | 1.7e-04 | -8.0 | 8.0 | 1.1e-15 | -0.90 | 0.04 | 0.66 | TRUE |
14 | Eye | Ctsc | gene expression | ENSRNOG00000016496 | 0.29 | 0.15 | top1 | 1 | 0.15 | 2.9e-03 | -6.8 | -6.8 | 7.9e-12 | 0.93 | 0.14 | 0.06 | FALSE |
15 | IL | Ctsc | gene expression | ENSRNOG00000016496 | 0.30 | 0.16 | top1 | 1 | 0.16 | 1.0e-04 | -7.1 | -7.1 | 1.2e-12 | 0.93 | 0.14 | 0.05 | FALSE |
16 | Liver | Ctsc | mRNA stability | ENSRNOG00000016496 | 0.05 | 0.04 | blup | 2515 | 0.04 | 1.8e-05 | 4.3 | 5.6 | 1.8e-08 | -0.82 | 0.99 | 0.01 | FALSE |
17 | NAcc | Ctsc | gene expression | ENSRNOG00000016496 | 0.12 | 0.09 | blup | 2516 | 0.12 | 3.3e-09 | -6.9 | -6.7 | 1.6e-11 | 0.93 | 0.65 | 0.35 | FALSE |
18 | NAcc | Grm5 | mRNA stability | ENSRNOG00000016429 | 0.07 | 0.02 | blup | 2630 | 0.04 | 1.0e-03 | 4.2 | -5.1 | 3.4e-07 | 0.68 | 0.78 | 0.17 | FALSE |
19 | OFC | Grm5 | mRNA stability | ENSRNOG00000016429 | 0.17 | 0.05 | blup | 2628 | 0.08 | 6.5e-03 | 4.4 | -5.2 | 1.7e-07 | 0.69 | 0.47 | 0.21 | FALSE |
20 | PL | Ctsc | gene expression | ENSRNOG00000016496 | 0.14 | 0.11 | enet | 87 | 0.13 | 8.2e-10 | -7.2 | -6.0 | 1.6e-09 | 0.75 | 0.36 | 0.64 | FALSE |
21 | PL | Grm5 | mRNA stability | ENSRNOG00000016429 | 0.04 | 0.03 | top1 | 1 | 0.03 | 1.3e-03 | -7.9 | -7.9 | 4.0e-15 | 0.92 | 0.09 | 0.07 | FALSE |
h2: Heritability estimate for the given transcriptomic model. PP3: Posterior probability of two distinct causal variants. PP4: Posterior probability of a single shared causal variant. joint: Whether the RNA phenotype is in the joint model.